# OnCo record mebendazole (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mebendazole/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mebendazole" ;
  schema:name "Mebendazole"@en ;
  schema:alternateName "Vermox"@en, "MBZ"@en ;
  schema:description "Mebendazole is a human worm medicine that has been through two very small cancer trials: a dose-finding study in brain tumours found a tolerable dose, and a study in advanced bowel and stomach cancers saw every patient's cancer keep growing."@en ;
  schema:url <https://onco.cc/drugs/mebendazole/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Mebendazole> ;
  schema:citation <https://doi.org/10.1002/cam4.3094>, <https://doi.org/10.1038/s41598-021-88433-y>, <https://doi.org/10.21873/anticanres.18276>, <https://doi.org/10.1001/jamanetworkopen.2026.16780> ;
  onco:status "phase-2" ;
  onco:modality "Oral benzimidazole anthelmintic for human worm infections, tested in two small cancer trials" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/fenbendazole-ivermectin-repurposing-claims/>, <https://onco.cc/technologies/drug-repurposing/> ;
  onco:drugs <https://onco.cc/drugs/ivermectin/>, <https://onco.cc/drugs/fenbendazole/>, <https://onco.cc/drugs/temozolomide/>, <https://onco.cc/drugs/lomustine/> ;
  onco:terms <https://onco.cc/terms/rp2d/>, <https://onco.cc/terms/off-label/>, <https://onco.cc/terms/preclinical/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-generic-repurposing/>, <https://onco.cc/bottlenecks/b-misinformation/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-patil-mebendazole-glioma-phase-1-cancer-med-2020/>, <https://onco.cc/key-papers/paper-mansoori-mebendazole-gi-cancer-phase-2a-sci-rep-2021/>, <https://onco.cc/key-papers/paper-hulscher-ivermectin-mebendazole-cohort-anticancer-res-2026/> .